These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33965937)

  • 21. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies.
    Schallier A; De Baets S; De Bruyne D; Dauwe K; Herpol M; Couck P
    Diagn Microbiol Infect Dis; 2021 Aug; 100(4):115403. PubMed ID: 34058541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody (Serology) Tests for COVID-19: a Case Study.
    West RM; Kobokovich A; Connell N; Gronvall GK
    mSphere; 2021 May; 6(3):. PubMed ID: 33980676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
    Sui Z; Dai X; Lu Q; Zhang Y; Huang M; Li S; Peng T; Xie J; Zhang Y; Wu C; Xia J; Dong L; Yang J; Huang W; Liu S; Wang Z; Li K; Yang Q; Zhou X; Wu Y; Liu W; Fang X; Peng K
    Signal Transduct Target Ther; 2021 May; 6(1):181. PubMed ID: 33972497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.
    Tang MS; Farnsworth CW
    Clin Chem; 2021 Apr; 67(5):707-709. PubMed ID: 33772260
    [No Abstract]   [Full Text] [Related]  

  • 28. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    McDonald SA; Miura F; Vos ERA; van Boven M; de Melker HE; van der Klis FRM; van Binnendijk RS; den Hartog G; Wallinga J
    Eur J Epidemiol; 2021 Jul; 36(7):735-739. PubMed ID: 34114187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
    Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
    J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
    Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
    J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interlaboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program.
    Tacker DH; Bashleben C; Long TC; Theel ES; Knight V; Kadkhoda K; Rhoads DD; Linden MA; Fink SL
    Arch Pathol Lab Med; 2021 May; 145(5):536-542. PubMed ID: 33461214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
    Bouman JA; Riou J; Bonhoeffer S; Regoes RR
    PLoS Comput Biol; 2021 Feb; 17(2):e1008728. PubMed ID: 33635863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2.
    Hoffman T; Kolstad L; Lindahl JF; Albinsson B; Bergqvist A; Rönnberg B; Lundkvist Å
    Viruses; 2021 May; 13(6):. PubMed ID: 34073484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Infection and the COVID-19 Pandemic Emergency: The Importance of Diagnostic Methods.
    Ciotti M; Benedetti F; Zella D; Angeletti S; Ciccozzi M; Bernardini S
    Chemotherapy; 2021; 66(1-2):17-23. PubMed ID: 33744904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay.
    Cobb BL; Sawalha AH
    Clin Immunol; 2022 Feb; 235():108791. PubMed ID: 34214649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 serology testing: Progress and challenges.
    Shi AC; Ren P
    J Immunol Methods; 2021 Jul; 494():113060. PubMed ID: 33915155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.